Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity

Currently available COVID-19 vaccines include inactivated virus, live attenuated virus, mRNA-based, viral vectored and adjuvanted protein-subunit-based vaccines. All of them contain the spike glycoprotein as the main immunogen and result in reduced disease severity upon SARS-CoV-2 infection. While w...

Descripción completa

Detalles Bibliográficos
Autores principales: Henze, Larissa, Braun, Julian, Meyer-Arndt, Lil, Jürchott, Karsten, Schlotz, Maike, Michel, Janine, Grossegesse, Marica, Mangold, Maike, Dingeldey, Manuela, Kruse, Beate, Holenya, Pavlo, Mages, Norbert, Reimer, Ulf, Eckey, Maren, Schnatbaum, Karsten, Wenschuh, Holger, Timmermann, Bernd, Klein, Florian, Nitsche, Andreas, Giesecke-Thiel, Claudia, Loyal, Lucie, Thiel, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927399/
https://www.ncbi.nlm.nih.gov/pubmed/36798117
http://dx.doi.org/10.3389/fimmu.2023.1056525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927399/
https://www.ncbi.nlm.nih.gov/pubmed/36798117
http://dx.doi.org/10.3389/fimmu.2023.1056525

Ejemplares similares